ACTH likely plays a role in myelolipoma formation; however, we found a decreased expression of the ACTH receptor (MC2R) and androgen receptor (AR) in myelolipoma tissue, and an increased expression in CAH adrenal tissue. The gene discussed is POMC; the disease is adrenal gland myelolipoma.